Synthomer PLC (OTCPK:SYYYF)
$ 1.18 (0%) Market Cap: 172.52 Mil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 0.14 GF Score: 62/100

Full Year 2025 Synthomer PLC Earnings Call Transcript

Apr 30, 2026 / 08:00 AM GMT
Release Date Price: $0.9098 (+56.00%)

Key Points

Positve
  • Synthomer PLC (SYHMY) delivered gross and EBITDA margin improvements despite challenging market conditions in 2025.
  • The company successfully refinanced its bank facilities, extending maturities to Q1 2029, providing financial stability.
  • Positive free cash flow was achieved for the year, with a reduction in net debt year-on-year.
  • The AS business division showed strong performance, regaining market share and enhancing margins.
  • Strategic focus on differentiated specialty products and targeted commercial strategies are driving growth in key regions.
Negative
  • Revenue for continuing business was down 9.9% on constant currency due to lower end market demand and competition.
  • Volume reductions in CCS and HPPM divisions led to negative operational leverage.
  • Underlying operating profit decreased by 21% for the year.
  • The company faces ongoing challenges from global tariff changes and competition from Asian companies.
  • Dividend remains suspended until leverage is reduced below two and a half times.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SYNTS.L - Synthomer PLC
Full Year 2025 Synthomer PLC Earnings Call
Apr 30, 2026 / 08:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to our 2025 full year results presentation. As usual, I'm here with Lily Liu, our CFO, and Faisal Taba, Head of Investor Relations, and together we look forward to answering your questions at the end.

In terms of the agenda, I will provide an overview of our performance and the further strategic progress we made in 2025. Despite an extended period of challenging market conditions. Lili will then walk through the 2025 numbers in more detail and update you on the balance sheet developments before I come back to present the actions we have been taking to deliver our strategy of focusing on differentiated specialty products for attractive end markets.

Then at the end, we will discuss what we have seen
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot